Duck Medicine and Vaccines Market
- 2026 年市場規模
- USD 2,560 Mn
- 2033 年預估規模
- USD 4,265 Mn
- 年複合成長率 CAGR
- 7.6%
以上數字由 Coherent Market Insights 於本報告中提出,量子訊息原樣引用。
授權報價
| Single User Price | $4,500 USD |
| Enterprise License | $10,000 USD |
完整報告名稱與涵蓋範圍
Duck Medicine and Vaccines Market, By Type (Medicine, Vaccines), By Application (Farm, Government), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
報告摘要
Duck farming plays a vital role in the poultry industry, which is one of the fastest-growing sectors in the world. Duck diseases are a major cause of concern because they can affect finances of small and landless farmers. Ducks are important to rural livelihoods because they provide a steady supply of meat and eggs. One of the most important measures to prevent outbreaks is to maintain the health of the ducks. Viruses have been reported to have more devastating consequences for duck productivity than other diseases that affect ducks. The most prevalent disease in ducks is Escherichia coli due to poor farm hygiene. Ducks are highly vulnerable to mycotoxins, notably aflatoxin, a toxic and carcinogenic metabolite of Aspergillus flavus that primarily affects the liver. This is a persistent issue that isn't always recognized. A toxin binder, which is a substance added to poultry feed in minute quantities to neutralize or immobilize harmful chemicals, mycotoxins or endotoxins should be included in duck diets on a regular basis. Proper vaccination and treatment can help prevent diseases in ducks.
Market Dynamics
The increasing research and development activities by scientists to develop vaccines for the diseases of ducks are expected to drive the market growth during the forecast period. For instance, in September 2020, scientists at the Department of Veterinary Microbiology, Kerala Veterinary and Animal Sciences University (KVASU), Mannuthy, a university aiming to promote sustainable and profitable animal production systems, developed a vaccine for Riemerellosis, a bacterial disease that causes significant mortality in ducks. In ducks, Riemerellosis causes 5-75 percent mortality and more than 50 percent mortality in ducklings under the age of five weeks.
Key features of the study
• This report provides an in-depth analysis of the global duck medicine and vaccines market, and provides market size (USD million) and compound annual growth rate (CAGR%) for the forecast period (2021–2028), considering 2020 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global duck medicine and vaccines market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Boehringer Ingelheim International GmbH., Ceva, YEBIO BIOENGINEERING CO., LTD., NAVETCO, Shangqiu Meilan Biological Engineering Co.,Ltd., Merck & Co., Inc., EGAVET, Bioveta, a.s., Jilin Zhengye Biological Products company limited, and Harbin Pharmaceutical Group Bio-vaccine Co. Ltd.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global duck medicine and vaccines market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global duck medicine and vaccines market
Market Segmentation
• By Type Insights (Revenue, USD Mn, 2020 - 2033)
o Medicine
o Vaccines
• By Application Insights (Revenue, USD Mn, 2020 - 2033)
o Farm
o Government
• By Region Insights (Revenue, USD Mn, 2020 - 2033)
o North America
U.S.
Canada
o Latin America
Brazil
Argentina
Mexico
Rest of Latin America
o Europe
Germany
U.K.
Spain
France
Italy
Russia
Rest of Europe
o Asia Pacific
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
o Middle East & Africa
GCC Countries
Israel
Rest of Middle East & Africa
• Key Players
o Boehringer Ingelheim International GmbH
o Ceva
o YEBIO BIOENGINEERING CO., LTD.
o NAVETCO
o Shangqiu Meilan Biological Engineering Co. Ltd.
o Merck & Co., Inc.
o EGAVET
o Bioveta, a.s.
o Jilin Zhengye Biological Products company limited
o Harbin Pharmaceutical Group Bio-vaccine Co. Ltd.
目錄 Table of Contents
Table of Contents
1. Research Objectives and Assumptions
o Research Objectives
o Assumptions
o Abbreviations
2. Market Purview
o Report Description
Market Definition and Scope
o Executive Summary
Market Snapshot, By Type
Market Snapshot, By Application
Market Snapshot, By Region
o Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
o Market Dynamics
o Drivers
o Restraints
o Market Opportunities
o Impact Analysis
o Market Trends
o Regulatory Scenario
o Reimbursement Scenario
o Technology Landscape
o Product Launches
o PEST Analysis
4. Global Duck Medicine and Vaccines Market, By Type, 2020 – 2033, (USD Mn)
o Overview
Market Share Analysis, 2020 and 2033 (%)
Y-o-Y Growth Analysis, 2020 – 2033
Segment Trends
o Medicine
Overview
Market Size and Forecast, and Y-o-Y Growth, 2020 – 2033, (USD Mn)
o Vaccines
Overview
Market Size and Forecast, and Y-o-Y Growth, 2020 – 2033, (USD Mn)
5. Global Duck Medicine and Vaccines Market, By Application, 2020 – 2033, (USD Mn)
o Overview
Market Share Analysis, 2020 and 2033 (%)
Y-o-Y Growth Analysis, 2020 – 2033
Segment Trends
o Farm
Overview
Market Size and Forecast, and Y-o-Y Growth, 2020–2033, (USD Mn)
o Government
Overview
Market Size and Forecast, and Y-o-Y Growth, 2020–2033, (USD Mn)
6. Global Duck Medicine and Vaccines Market, By Region, 2020 – 2033, (USD Mn)
o Introduction
Market Share Analysis, By Region, 2020 and 2033 (%)
Y-o-Y Growth Analysis, For Regions, 2020–2033
Regional Trends
o North America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2033, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2033, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 – 2033, (USD Mn)
o U.S.
o Canada
o Latin America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2033, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2033, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 – 2033, (USD Mn)
o Brazil
o Mexico
o Argentina
o Rest of Latin America
o Europe
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2033, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2033, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 – 2033, (USD Mn)
o UK
o Germany
o Italy
o France
o Spain
o Russia
o Rest of Europe
o Asia Pacific
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2033, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2033, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 – 2033, (USD Mn)
o China
o India
o Japan
o ASEAN
o Australia
o South Korea
o Rest of Asia Pacific
o Middle East
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2033, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2033, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 – 2033, (USD Mn)
o GCC
o Israel
o Rest of Middle East
o Africa
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2033, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2033, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 – 2033, (USD Mn)
o North Africa
o Central Africa
o South Africa
7. Competitive Landscape
o Boehringer Ingelheim International GmbH.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
o Ceva
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
o YEBIO BIOENGINEERING CO., LTD
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
o NAVETCO
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
o Shangqiu Meilan Biological Engineering Co.,Ltd
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
o Merck & Co., Inc.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
o EGAVET
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
o Bioveta, a.s.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
o Jilin Zhengye Biological Products company limited
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
o Harbin Pharmaceutical Group Bio-vaccine Co. Ltd.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
8. Section
o Research Methodology
o About Us
提及公司
同分類最新報告(醫療與生命科學)
常見問題
這份報告可以先索取樣本嗎?
可以。建議購買前先申請樣本,提出申請後約 2 個工作天內提供,您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算?
報告以美元標價,台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本(單人/多人/企業全站)價格不同,量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付?如何付款?
一般 3–7 個工作天交付,實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票,30 天內電匯付款即可。
量子訊息有限公司為 Coherent Market Insights 在台灣的授權代理,提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們